Vaginal cancers and human papilloma virus.

Cancer is known as a considerable disease with high morbidity and mortality within adult's populations. There are different types of cancers with a wide range of distributions and risk factors worldwide. Vaginal cancers are limited but may lead to high morbidity and mortality. Vaginal cancers have several predisposing factors, but HPV is recognized as the most important viral causative agent for vaginal cancers. There are different types of diagnostics for detecting HPV vaginal cancers. A qualified Pap smear is recognized as an invaluable screening program for early detection of HPV vaginal cancers. The incidence of vaginal cancers has significantly decreased in industrialized countries because of qualified performance of Pap smear. The most morbidity and mortality relating to vaginal cancers are reported from developing countries. There are different types of treating procedures including cryotherapy, laser therapy, electrosurgical procedures, radiotherapy and pharmacotherapy. The result of treatments in patients is checked via molecular diagnostic techniques which are known as gold standard approaches. Limitation of risk factors and application of vaccines are confirmed as favor preventing methods. The aim of this article is to review the subtitle of vaginal cancer staging, epidemiology of HPV vaginal cancers, viral characteristics and pathogenesis of HPV vaginal cancers, clinical demonstrations of HPV vaginal cancers diagnosis, treatment and prevention. [ABSTRACT FROM AUTHOR]